Institution statistics

INSERM - TRANSFERT SA - France 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:700-800
Networking Rank (Reputation):500-600
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:300-400
Project Leadership Index:600-700
2014
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):900-1000
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:64
Partner Constancy:42
Project Leadership Index:61
Diversity Index:39
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:64
Networking Rank (Reputation):500-600
Networking Rank (Reputation):500-600
Partner Constancy:40
Project Leadership Index:69
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:500-600
Total Project Funding per Partner:300-400
Total Number of Projects:600-700
Networking Rank (Reputation):800-900
Partner Constancy:300-400
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):400-500
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):500-600
Partner Constancy:100-200
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:800-900
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 82
As coordinator: 2
As participant: 80
Sole participant: 0
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 5.979.607 427.115 1
2016 0 41.731.414 1.484.174 4
2015 0 21.630.050 1.611.188 4
2014 0 15.674.149 1.019.943 2
2013 5.900.720 59.723.277 6.497.480 1 9
2012 1.999.985 41.700.816 3.931.037 1 7
2011 0 25.245.825 2.324.132 5
2010 0 43.611.847 3.339.244 9
2009 0 20.167.421 1.757.007 4
2008 0 28.204.007 2.881.525 8
2007 0 12.700.000 925.735 2
2006 0 11.919.720 1.311.007 5
2005 0 45.283.972 2.652.993 11
2004 0 55.974.059 2.324.409 9
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE60
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE13
KAROLINSKA INSTITUTE12
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS9
COMMISSARIAT A L'ENERGIE ATOMIQUE9
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE9
KING'S COLLEGE LONDON9
KATHOLIEKE UNIVERSITEIT LEUVEN8
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS7
INSTITUT PASTEUR7
MEDICAL RESEARCH COUNCIL7
UNIVERSITE DE GENEVE7
UNIVERSITY COLLEGE LONDON7
UNIVERSITY OF WALES CARDIFF7
MEDIZINISCHE HOCHSCHULE HANNOVER6
UNIVERSITAETSKLINIKUM HEIDELBERG6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
DEPARTMENT OF HEALTH5
EUROPEAN MOLECULAR BIOLOGY LABORATORY5
HEALTH PROTECTION AGENCY5
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI5
PHILIPPS UNIVERSITAET MARBURG5
UNIVERSITE DE LIEGE5
UNIVERSITY OF GLASGOW5
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER4
CORIS BIOCONCEPT SPRL4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
FOLKHALSOMYNDIGHETEN4
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA4
GENETHON4
INSTITUTO DE SALUD CARLOS III4
LEIDEN UNIVERSITY MEDICAL CENTER4
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE4
MEDIZINISCHE UNIVERSITAET WIEN4
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE4
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
THE HEBREW UNIVERSITY OF JERUSALEM4
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA4
UNIVERSITAET LEIPZIG4
UNIVERSITAET ULM4
UNIVERSITAET ZUERICH4
UNIVERSITAETSKLINIKUM BONN4
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI4
UNIVERSITEIT ANTWERPEN4
UNIVERSITY OF BIRMINGHAM4
VRIJE UNIVERSITEIT BRUSSEL4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN3
CELLARTIS AB3
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE3
DEBRA EUROPE3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR3
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT3
FUNDACAO OSWALDO CRUZ3
GOETEBORGS UNIVERSITET3
HADASSAH MEDICAL ORGANIZATION3
HELLENIC PASTEUR INSTITUTE3
ISTITUTO SUPERIORE DI SANITA3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MEDIZINISCHE UNIVERSITAET GRAZ3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
MOSAIQUES DIAGNOSTICS3
PHILIPPSUNIVERSITAET MARBURG3
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY3
TEL AVIV UNIVERSITY3
THE UNIVERSITY OF BRISTOL3
THE UNIVERSITY OF LIVERPOOL3
THE UNIVERSITY OF NOTTINGHAM3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITAET STUTTGART3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITAETSKLINIKUM FREIBURG FUER DIE MEDIZINISCHE FAKULTAET DER ALBERT LUDWIGS UNIVERSITAET3
UNIVERSITE CATHOLIQUE DE LOUVAIN3
UNIVERSITEIT MAASTRICHT3
UPPSALA UNIVERSITET3
VIB3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACADEMISCH ZIEKENHUIS LEIDEN2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
BIOMAY2
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG2
CELLGENIX TECHNOLOGIE TRANSFER2
CENTRE HOSPITALIER CHRETIEN ASBL2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE NATIONALE DE LA RECHERCHE SCIENTIFIQUE2
CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC2
CORIS BIOCONCEPT2
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
FONDAZIONE PER L'ISTITUTO DI RICERC A IN BIOMEDICINA2
GENOWAY2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HACETTEPE UNIVERSITESI2
HEINRICHHEINEUNIVERSITAET DUESSELDORF2
Constancy:

Total number of partners:1116

Partner loyalty:
Frequent Partner: (> 2 projects): 417
Rare Partner: 699

Frequent / Rare Partner Ratio: 0.6

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES60
RTD HORIZONTAL TOPICS26
SOCIAL AND ECONOMIC CONCERNS12
AGRICULTURE AND MARINE RESOURC1
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-01-01Crimean-Congo Haemorrhagic Fever Vaccine CCHFVaccineparticipant5.979.60714
2016-10-01A global alliance for Zika virus control and prevention ZIKAllianceparticipant11.964.20953
2016-01-01Investigating the impact of meditation training on mental health and wellbeing in the ageing population MEDIT-AGEINGparticipant6.134.75610
2016-01-01European Research Infrastructure on Highly Pathogenic Agents 2 ERINHA2participant1.443.92716
2016-01-01European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates EHVAparticipant22.188.52240
2015-11-01Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases JPsustaiNDparticipant2.043.28416
2015-09-01Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients MIROCALSparticipant5.980.43512
2015-05-01Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension ENSAT-HTparticipant7.607.33713
2015-05-01Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone FAIR-PARK-IIparticipant5.998.99415
2014-02-01Nanotherapeutics for antibiotic resistant emerging bacterial pathogens NAREBparticipant9.674.15815
2014-02-01Anti-Parasitic Drug Discovery in Epigenetics A-PARADDISEparticipant5.999.99116
2013-11-01Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders BRAINTRAINparticipant5.998.66110
2013-10-01"Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis" MYASTERIXcoordinator5.900.7205
2013-10-01"Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntington’s disease" REPAIR-HDparticipant6.000.0009
2013-09-01Point-of-care tests to revolutionise the clinical management of patients infected by Hepatitis C virus POC-HCVparticipant5.991.4265
2013-09-01Targeting cardiac fibrosis for heart failure treatment FIBRO-TARGETSparticipant6.000.00011
2013-07-01Developing Innovative Outreach and Dialogue on responsible nanotechnologies in EU civil society NANODIODEparticipant1.899.84214
2013-03-01Biomarkers of renal graft injuries in kidney allograft recipients BIOMARGINparticipant6.000.00013
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2013-02-01Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility NANOATHEROparticipant9.833.34816
2013-01-01SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING AGEDBRAINSYSBIOparticipant6.000.00014
2012-11-01Metagenomics in Cardiometabolic Diseases METACARDISparticipant11.999.99215
2012-10-01Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes DIABIL-2participant5.900.0006
2012-10-01Highlighting EU-funded Health research results via TV media and the internet HIGHLIGHTparticipant999.4906
2012-09-01Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems. EE-ASIparticipant5.983.8718
2012-09-01European Network of Knowledge Transfer in Health ENTENTEcoordinator1.999.9857
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Chips for Life C4Lparticipant2.876.3008
2012-01-01Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MYRparticipant2.999.49810
2011-12-01Innovative strategies to generate human hepatocytes for treatment of metabolic Liver diseases: Tools for personalized cell therapy InnovaLivparticipant5.884.1717
2011-03-01Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector GENEGRAFTparticipant4.961.65410
2011-01-01Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates TINN2participant5.000.00016
2011-01-01HEPATIC MICROFLUIDIC BIOREACTOR HeMiBioparticipant4.700.00013
2011-01-01Stem Cells for Relevant Efficient Extended and Normalized Toxicology SCR&TOXparticipant4.700.00015
2010-12-01Mechanisms of the Development of ALLergy MEDALLparticipant11.990.93923
2010-11-01European Research Infrastructure on Highly Pathogenic Agents ERINHAparticipant3.600.00025
2010-11-01Syndromic approach to Neglected Infectious Diseases (NID) at primary health care level: an international collaboration on integrated diagnostic-treatment platforms NIDIAGparticipant5.000.00013
2010-11-01Host and viral factors in acute hepatitis C HepaCuteparticipant2.999.50017
2010-10-01Crimean Congo Hemorrhagic Fever; Modern Approaches to Diagnostics, Surveillance, Prevention, Therapy and Preparedness CCH Feverparticipant3.000.00017
2010-10-01Post-infectious immune reprogramming and its association with persistence and chronicity of respiratory allergic diseases PreDictaparticipant5.991.60013
2010-09-01Coordination Action in support of the implementation of a Joint Programming Initiative for Combating Neurodegenerative Diseases, in particular Alzheimer’s disease JUMPAHEADparticipant2.000.00013
2010-01-01Schistosoma Epigenetics - Targets, Regulation, New Drugs SEtTReNDparticipant3.299.9989
2010-01-01The role of intestinal microflora in non-alcoholic fatty liver disease (NAFLD) FLORINASHparticipant5.729.8106
2009-12-01Myasthenias, a group of immune mediated neurological diseases: from etiology to therapy FIGHT-MGparticipant5.917.42112
2009-10-01Health Competence in Europe HEALTHCOMPETENCEparticipant800.0003
2009-01-01Understanding and combating human age-related muscle weakness MYOAGEparticipant11.200.00018
2009-01-01Circuit specific approaches to retinal diseases RETICIRCparticipant2.250.0006
2008-11-01Evaluation of antibiotics (ciprofloxacin and fluconazole) for the treatment of infections in preterm and term neonates TINNparticipant5.161.00016
2008-10-01Nonhuman adenovirus vectors for gene transfer to the brain BRAINCAVparticipant2.984.99911
2008-10-01Development of culture conditions for the differentiation of hES cells into hepatocytes LIV-ESparticipant2.999.8797

overview shows latest 50 from 82 projects (2000-01-01 - 2017-12-31)
A full list of projects can be found here:

Alias institution names:
  • INSERM TRANSFERT
  • INSERMTRANSFERT

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: